Yes, modestly. In men with BPH treated with dutasteride 0.5 mg daily for 4 years, the FDA label records a median increase in serum testosterone of 19% at 1 year, 19% at 2 years, 26% at 3 years and 22% at 4 years, and states that mean and median levels remained within the physiologic range. In healthy volunteers, the median increase was 17.9% at 8 weeks, and levels had returned to baseline 24 weeks after stopping. The rise happens because dutasteride blocks the conversion of testosterone to dihydrotestosterone (DHT). Dutasteride is FDA-approved in the United States for benign prostatic hyperplasia only; use for hair loss is off-label.
Why Dutasteride Increases Testosterone
Under normal conditions, a portion of circulating testosterone is converted to DHT by 5-alpha reductase. Dutasteride inhibits that conversion: in men with BPH treated for 4 years, the label records a median decrease in serum DHT of 94% at 1 year, 93% at 2 years and 95% at both 3 and 4 years. The testosterone that would have been converted remains as testosterone, which is the straightforward explanation for the modest net rise in serum levels.
How Much Does Testosterone Increase?
The figures come straight from the label’s pharmacodynamics section: a median increase of 19% at 1 and 2 years, 26% at 3 years and 22% at 4 years in men with BPH, with mean and median levels remaining within the physiologic range. In healthy volunteers given 0.5 mg daily for 52 weeks, the statistically significant baseline-adjusted mean increase versus placebo was 97.1 ng/dL for total testosterone at 8 weeks. The label does not report any adverse reaction attributed to this rise.
Testosterone Replacement Therapy (TRT) Considerations
Patients on TRT who also take dutasteride should be aware that their total testosterone may read slightly higher on lab tests. Combining a 5-alpha reductase inhibitor with testosterone therapy to blunt DHT-mediated effects is an off-label practice: no such combination is described in the dutasteride label, and no trial supporting it is cited there. Anyone doing it should be doing it under the supervision of the prescriber managing their TRT.
Estrogen Effects
It is often assumed that the extra testosterone converts to estradiol via aromatase, and that the shifted testosterone-to-estrogen ratio explains dutasteride-related gynecomastia. The label does not support the first half of that chain. In healthy volunteers treated for 52 weeks, it reports no clinically significant change compared with placebo in estradiol, sex hormone-binding globulin, luteinizing hormone, follicle-stimulating hormone, free T4 or dehydroepiandrosterone. Breast disorders are a real, recorded adverse reaction, but the estradiol mechanism remains a proposed explanation rather than a measured one.
All interactions · How dutasteride works · Side effects
Sources
- FDA. Avodart (dutasteride) prescribing information, Clinical Pharmacology section 12.2 (Pharmacodynamics). accessdata.fda.gov